Bloomage BioTechnology 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yan Zhao

최고 경영자

CN¥2.0m

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	0.02%
경영진 평균 재임 기간	4.3yrs
이사회 평균 재임 기간	4.4yrs

최근 관리 업데이트

Recent updates

CEO

Yan Zhao (58 yo)

no data

테뉴어

CN¥2,024,900

보상

Ms. Yan Zhao serves as the Chairwoman at Pando Group Limited. She is also the majority shareholder in and serves as Chairman and Executive Director of Bloomage BioTechnology Corporation Limited and serves...

리더십 팀

이름	위치	테뉴어	보상	소유권
Yan Zhao	Chairman & GM	no data	CN¥2.02m	0.024% CN¥ 6.7m
Jiajun Guo	Deputy GM & Director	no data	CN¥925.30k	0.012% CN¥ 3.2m
Xueping Guo	Deputy GM of Core Technician & Director	no data	CN¥946.70k	0.017% CN¥ 4.7m
Yizheng Li	Deputy GM	no data	CN¥1.70m	데이터 없음
Aihua Liu	Deputy General Manager	no data	CN¥1.82m	0.015% CN¥ 4.1m
Guixin Xu	Deputy General Manager	5.7yrs	CN¥734.90k	0.0092% CN¥ 2.5m
Gao Yi	Deputy General Manager	3.8yrs	CN¥1.00m	0.0026% CN¥ 726.2k
Luan Yizheng	Deputy General Manager	4.9yrs	CN¥1.01m	0.012% CN¥ 3.2m
Hui Wang	CFO & Financial Director	less than a year	데이터 없음	데이터 없음
Tao Tian	Head of Accounting & Accounting Supervisor	no data	데이터 없음	데이터 없음

4.3yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: 688363 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yan Zhao	Chairman & GM	no data	CN¥2.02m	0.024% CN¥ 6.7m
Jiajun Guo	Deputy GM & Director	no data	CN¥925.30k	0.012% CN¥ 3.2m
Xueping Guo	Deputy GM of Core Technician & Director	no data	CN¥946.70k	0.017% CN¥ 4.7m
Yizheng Li	Deputy GM	no data	CN¥1.70m	데이터 없음
Yingqian Wang	Independent Director	5.7yrs	CN¥150.00k	데이터 없음
Fuguo Cao	Independent Director	5.7yrs	CN¥150.00k	데이터 없음
Changmei Zhao	Supervisor	4.4yrs	데이터 없음	데이터 없음
Dongni Li	Employee Representative Supervisor	4.4yrs	데이터 없음	데이터 없음
Jing Yu	Chairman of the Supervisory Board	no data	데이터 없음	데이터 없음
Songyan Zou	Director	2.6yrs	CN¥626.90k	0.0019% CN¥ 517.1k
Yuan Fan	Director	2.6yrs	CN¥862.90k	0.0038% CN¥ 1.0m
Guanting Chen	Independent Director	2.6yrs	CN¥150.00k	데이터 없음

4.4yrs

평균 재임 기간

54.5yo

평균 연령

경험이 풍부한 이사회: 688363 의 이사회는 경험(평균 재직 기간 4.4 년)으로 간주됩니다.

Bloomage BioTechnology 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Recent updates

Bloomage Showcases New Functional Food Ingredients for the Japanese Market at Hi Japan 2024

Third quarter 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.19 in 3Q 2023)

Investor sentiment deteriorates as stock falls 24%

New minor risk - Share price stability

Bloomage BioTechnology Corporation Limited to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Bloomage Showcases Key Bioactive Substances At CPHI and HI Korea

Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.46 in 2Q 2023)

Bloomage Launches MitoPQQ™ and Presents Hyaluronic Acid Research at IFT FIRST Expo 2024

Bloomage BioTechnology Corporation Limited to Report First Half, 2024 Results on Aug 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.51 (vs CN¥0.42 in 1Q 2023)

Bloomage BioTechnology Corporation Limited to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released: EPS: CN¥1.22 (vs CN¥2.02 in FY 2022)

Now 20% overvalued

Investor sentiment deteriorates as stock falls 17%

Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.43 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.46 (vs CN¥0.56 in 2Q 2022)

Bloomage BioTechnology Corporation Limited (SHSE:688363) announces an Equity Buyback for CNY 300 million worth of its shares.

Less than half of directors are independent

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령